-clidine/-clidinium
Drugs that activate or block muscarinic acetylcholine receptors.
- Drugs ending in -clidine/-clidinium: 7
- Approved somewhere: 3
- With a US drug page: 4
- Stem
- -clidine/-clidinium
- Class
- Drugs that activate or block muscarinic acetylcholine receptors
Approved and clinical-stage drugs in ChEMBL whose names ending in -clidine/-clidinium, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Aclidinium | Approved | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Procyclidine | Approved | CHRM1 | Muscarinic acetylcholine receptor M1 antagonist |
| Umeclidinium | Approved | CHRM3 | Muscarinic acetylcholine receptor M3 antagonist |
| Aceclidine | Phase 3 | — | — |
| Emraclidine | Phase 2 | — | — |
| Gacyclidine | Phase 2 | — | — |
| Talsaclidine | Phase 2 | CHRM3, CHRM2, CHRM1 | Muscarinic acetylcholine receptor M3 partial agonist |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO